{"id":55502,"date":"2023-04-04T15:03:23","date_gmt":"2023-04-04T13:03:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/"},"modified":"2023-04-04T15:03:23","modified_gmt":"2023-04-04T13:03:23","slug":"qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/","title":{"rendered":"Qnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor"},"content":{"rendered":"
\n

RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today Mitch Zeller has joined the company as an advisor to focus on policy and regulatory strategy. Qnovia\u2019s lead asset, QN-01, is an application to FDA\u2019s Center for Drug Evaluation and Research (CDER), with the potential to be the first prescription inhaled smoking cessation therapy.\n<\/p>\n

<\/a><\/p>\n

\nMr. Zeller has 40 years of experience working on FDA issues. In his advisory role, he will advise Qnovia on the optimal policy and regulatory strategy that will advance a framework for the development and advancement of new smoking cessation therapies to support the company\u2019s strategy as it advances through the drug approval process in the U.S. and in other global markets.\n<\/p>\n

\n\u201cI am excited to serve as an advisor to Qnovia at this pivotal stage in the company\u2019s lifecycle,\u201d said Mitch Zeller. \u201cThere have been no new therapies approved for smoking cessation in over a decade. Although most smokers are concerned about their health and want to quit, existing products simply don\u2019t work all that well in the real world. Qnovia is taking a unique approach and is committed to developing a safe and effective medical therapy that can help more smokers successfully quit. An inhalable smoking cessation therapy is a potential game-changer, and I look forward to helping the company achieve its goal of ending the death and disease caused by smoking.\u201d\n<\/p>\n

\n\u201cMitch brings a wealth of regulatory experience and an unparalleled perspective to our team as we work to advance our lead smoking cessation asset through FDA\u2019s 505 (b)(2) pathway and ultimately to those patients in need,\u201d said Brian Quigley, CEO of Qnovia. \u201cThe successful development of QN-01 not only represents a potential breakthrough in smoking cessation treatment but also can validate Qnovia\u2019s platform technology as we expand development in additional therapeutic areas including asthma, COPD, pain management, depression and anxiety.\u201d\n<\/p>\n

\nMr. Zeller is an important addition to Qnovia, given his leadership and understanding of the public health, policy, product and regulatory environment around smoking cessation. He was the Director of FDA\u2019s Center for Tobacco Products from March 2013 to April 2022, where he shaped regulatory policy and participated in intra-agency planning for comprehensive nicotine policy. He continues to remain dedicated to advancing the development of new medicinal cessation therapies for patients.\n<\/p>\n

\nAbout Qnovia, Inc.<\/b>\n<\/p>\n

\nQnovia, Inc., formerly Respira Technologies, Inc., is a pharma company focused on developing and commercializing proprietary inhalation device technologies to improve patient outcomes. The company\u2019s drug delivery platform is the first orientation-agnostic, portable vibrating mesh nebulizer that effectively operates in any position held by the patient. Qnovia sees significant opportunity to utilize its drug delivery technologies to improve the treatment of asthma, COPD, vaccine delivery, pain management, and several generic as well as select investigational new drugs. The company was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies. The company can be found at www.qnovia.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations:<\/b>
Kiki Patel
\n
Vice President
\n
Gilmartin Group
\n
kiki@gilmartinir.com<\/a>\n<\/p>\n

\nMedia Relations:<\/b>
Richard Laermer
\n
CEO
\n
RLM Public Relations
\n
212-741-5106 X 216
\n
Qnovia@RLMpr.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today Mitch Zeller has joined the company as an advisor to focus on policy and regulatory strategy. Qnovia\u2019s lead asset, QN-01, is an application to FDA\u2019s Center for Drug Evaluation and Research (CDER), with the potential to be … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55502","6":"format-standard","7":"category-industry"},"yoast_head":"\nQnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today Mitch Zeller has joined the company as an advisor to focus on policy and regulatory strategy. Qnovia\u2019s lead asset, QN-01, is an application to FDA\u2019s Center for Drug Evaluation and Research (CDER), with the potential to be ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-04T13:03:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230404005061\/en\/1753097\/21\/Qnovia.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Qnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor\",\"datePublished\":\"2023-04-04T13:03:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/\"},\"wordCount\":553,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230404005061\\\/en\\\/1753097\\\/21\\\/Qnovia.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/\",\"name\":\"Qnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230404005061\\\/en\\\/1753097\\\/21\\\/Qnovia.jpg\",\"datePublished\":\"2023-04-04T13:03:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230404005061\\\/en\\\/1753097\\\/21\\\/Qnovia.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230404005061\\\/en\\\/1753097\\\/21\\\/Qnovia.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/","og_locale":"en_US","og_type":"article","og_title":"Qnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor - Pharma Trend","og_description":"RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today Mitch Zeller has joined the company as an advisor to focus on policy and regulatory strategy. Qnovia\u2019s lead asset, QN-01, is an application to FDA\u2019s Center for Drug Evaluation and Research (CDER), with the potential to be ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-04T13:03:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230404005061\/en\/1753097\/21\/Qnovia.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Qnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor","datePublished":"2023-04-04T13:03:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/"},"wordCount":553,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230404005061\/en\/1753097\/21\/Qnovia.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/","url":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/","name":"Qnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230404005061\/en\/1753097\/21\/Qnovia.jpg","datePublished":"2023-04-04T13:03:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230404005061\/en\/1753097\/21\/Qnovia.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230404005061\/en\/1753097\/21\/Qnovia.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/qnovia-inc-announces-former-director-of-fdas-center-for-tobacco-products-mitch-zeller-as-policy-and-regulatory-strategy-advisor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Qnovia, Inc. Announces Former Director of FDA\u2019s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55502"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55502\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55502"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}